PTV News Review


PTV's Dr Fintan Walton interviews top executives from leading pharmaceutical and biotechnology companies.

PharmaTelevision News Review is available on Subscription as part of PharmaTelevision Premium Content.
Scroll: Previous
TVM Capital:
Roche: Deals,
GlaxoSmithKline:
Galapagos:
Grant Thornton: UK
Argos Therapeutics:
Living Cell
Ernst & Young: The
Novartis:
J.P. Morgan: The
Merck Serono:
Minomic: Innovative
Biota: Success With
Starpharma:
Manitoba STEM:
BIOTECanada: Why
Intersuisse
GBS Venture
Roche: Partnering
Bailard
PlantBio Trust:
Eli Lilly: The
The Hon Peter
Paul Cheever
Pfizer: An Ideal
Biosceptre: A New
Biotechnology in
Roche: What they
The Ewing Marion
Rexahn
Sutro Biopharma:
American Gene
The Michael J Fox
BioBay: Using
Fountain Medical
BayBio's year and
ChinaBio LLC: China
Approaching
Moving forward:
Aisling Capital:
Genentech: Becoming
MPM Capital: The
Celtic Pharma:
Thiakis’ origins,
TVM Capital:
Chroma
Stemgent: Fate,
MolMed’s Key
BIA: Bringing
BIA: Funding and
Part 1: Is the
Part 2: Is the
Part 1: The Golden
Part 2: The Golden
Merck Serono
Part 1: 2009 and
Part 2: 2009 and
Johnson & Johnson:
Pfizer’s
The New Merck
BIO and 2009 – the
InDex
sanofi-aventis’ New
Roche:Genentech
Part 1: The future
Part 2: The future
Part 3: The future
1. Out-licensing by
2. Out-licensing by
The credit crunch
The Gateway to
Immunocore &
The Wellcome Trust:
Biotica’s Balancing
Reinventing Roche’s
Burnham’s
Compugen’s Powers
Idera
Nicast’s New
GlobeImmune’s
SeraCare’s
KaloBios’
Hadasit
Oncolytics Biotech:
What’s Next For
How SkyePharma
The Allergan Model
Menarini’s Global
Will GSK’s
The Diversification
Pfizer and Wyeth’s
The EBD Group's
Genera Biosystems:
China’s Emergence
The Future of
Bristol-Myers
Biota Focuses on
Starpharma’s
Merck Goes Back to
Roche Seeks Out CNS
New Pharma Partner
Pfizer’s Investment
Was Biotech Failed
AusBiotech Evolves
How Government Can
Victorian
Takeda Strengthens
How Do Eli Lilly &
Oxford BioMedica:
Sir Michael Rawlins
Early Stage Spin
Novacta Biosystems:
Recent Deals
Cancer Research
PharmaVentures:
DuBiotech: The
Antisoma Plc
InterMed Discovery:
EGEN: A Research
Cellzome and
Xceleron: Changing
Polyphor Ltd:
Stemgent: Supplying
EBD Group: Carola
Artisan Draws
La Jolla
Paul Capital
BioInvent’s Deal
EuropaBio: Working
BIO: The Future
Neuropharma: A New
Karus Therapeutics:
ValiRx: Bioscience
Mercury
AM-Pharma:
The GI Company:
Takeda Research
Maryland DBED: Will
Addex
Apposite Capital:
Archimedes Pharma:
EUSA Pharma:
Bird & Bird: A View
Synta
Novarix: Interview
NovaQuest:
London Genetics:
Xanthus: Evolving
Uniseed Management
Tissue Therapies’
Speedel’s Renin
Micromet: From
BayBio: Impact of
AusBiotech: An
Ablynx’s Success
Alchemia: Drug
Stem Cell Sciences:
Phylogica: Business
Merck & Co.:
KaloBios: The
IEDC: Indiana: A
GE Healthcare
MorphoSys:
McKenna Long &
eG Capital:
Simmons & Simmons:
Johnson & Johnson:
Bristol-Myers
Sofinnova Partners:
Piramed Pharma: The
Ganymed Pharma:
Faust
Eli Lilly & Co.:
Oxford Technology
PharmaDeals
Novosom: Strategies
BIOCOM: Challenges
Midatech: The Story
Gene Bridges: Life
Borean Pharma:
Novartis Breaks the
Lexicon
Genentech: Driven
Bingham McCutchen:
F. Hoffmann-La
Oxford BioMedica:
BIO: Issues and
The Pharmaceutical
NicOx: The Rise of
Celltech: The Three
Celltech: The Birth
BioXcel
The Pharmaceutical
ZymoGenetics:
Sareum and
Ipso Ventures
Implicit
Synosia
Nektar
Glide Pharma: The
Johnson & Johnson:
PharmaTelevision:
Meet the Experts
Meet the Experts:
Speedel: Dr Alice
BayBio: Matthew
Zogenix: Stephen
F. Hoffmann-La
MorphoSys: Dr Simon
Biota: Peter Cook,
AstraZeneca: Rob
Meet the Experts:
Simcere
Galapagos: Onno van
Evotec: Dr Mark
Archimedes Pharma:
Meet the Experts:
Meet the Experts:
ZymoGenetics: 25
Meet the Experts:
Scroll: Next
PTV News Review Feeds:
Apply to be interviewed
Do you have something to share? Give an interview!
Hugo Tickler
T: +44 (0)1865 332 709